{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:10:35Z","timestamp":1793369435677,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T00:00:00Z","timestamp":1549670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ijid.2019.02.005","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T12:22:01Z","timestamp":1550146921000},"page":"128-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":360,"special_numbering":"C","title":["Antibiotic penetration into bone and joints: An updated review"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0369-9094","authenticated-orcid":false,"given":"Abrar K.","family":"Thabit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania F.","family":"Fatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam S.","family":"Bamakhrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola A.","family":"Barnawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana O.","family":"Basudan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahad F.","family":"Alhejaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2019.02.005_bib0005","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0306-3623(90)91007-E","article-title":"Cephalexin concentrations in human serum, gingiva, and mandibular bone following a single oral administration","volume":"21","author":"Akimoto","year":"1990","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.ijid.2019.02.005_bib0010","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0278-2391(94)90447-2","article-title":"Cefadroxil concentrations in human serum, gingiva, and mandibular bone following a single oral administration","volume":"52","author":"Akimoto","year":"1994","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijid.2019.02.005_bib0015","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jcms.2008.06.003","article-title":"Concentrations of piperacillin-tazobactam in human jaw and hip bone","volume":"36","author":"Al-Nawas","year":"2008","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.ijid.2019.02.005_bib0020","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/ejcts\/ezu491","article-title":"Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting","volume":"48","author":"Andreas","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ijid.2019.02.005_bib0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/pgmj.54.628.65","article-title":"Penetration into bone and tissues of clindamycin phosphate","volume":"54","author":"Baird","year":"1978","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ijid.2019.02.005_bib0030","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/cid\/civ482","article-title":"2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults","volume":"61","author":"Berbari","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2019.02.005_bib0035","first-page":"2265","article-title":"Diffusion in bone tissue of antibiotics","volume":"28","author":"Boselli","year":"1999","journal-title":"Presse Med"},{"key":"10.1016\/j.ijid.2019.02.005_bib0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1179\/joc.2002.14.1.54","article-title":"Penetration of piperacillin\/tazobactam (4g\/500mg) into synovial tissue","volume":"14","author":"Boselli","year":"2002","journal-title":"J Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0045","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/jac\/dkm296","article-title":"Diffusion of ertapenem into bone and synovial tissues","volume":"60","author":"Boselli","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0050","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1179\/joc.2003.15.2.134","article-title":"Diffusion of cefepime into cancellous and cortical bone tissue","volume":"15","author":"Breilh","year":"2003","journal-title":"J Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/17453674.2017.1373497","article-title":"Bone and subcutaneous adipose tissue pharmacokinetics of vancomycin in total knee replacement patients","volume":"89","author":"Bue","year":"2018","journal-title":"Acta Orthop"},{"key":"10.1016\/j.ijid.2019.02.005_bib0060","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0300-9785(78)80035-0","article-title":"Concentrations of azidocillin, erythromycin, doxycycline and clindamycin in human mandibular bone","volume":"7","author":"Bystedt","year":"1978","journal-title":"Int J Oral Surg"},{"key":"10.1016\/j.ijid.2019.02.005_bib0065","series-title":"Physics of the body","author":"Cameron","year":"1999"},{"key":"10.1016\/j.ijid.2019.02.005_bib0070","series-title":"Performance standards for antimicrobial susceptibility testing: twenty-seventh informational supplement [document M100-S28]","author":"Clinical and Laboratory Standards Institute","year":"2018"},{"key":"10.1016\/j.ijid.2019.02.005_bib0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/13.suppl_C.23","article-title":"Rifampicin in the treatment of osteoarticular infections due to staphylococci","volume":"13 Suppl C","author":"Cluzel","year":"1984","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0080","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1128\/JCM.01246-12","article-title":"Ampicillin susceptibility can predict in vitro susceptibility of penicillin-resistant, ampicillin-susceptible Enterococcus faecalis Isolates to amoxicillin but not to imipenem and piperacillin","volume":"50","author":"Conceicao","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2019.02.005_bib0085","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.diagmicrobio.2003.10.013","article-title":"Concentrations of moxifloxacin in serum and synovial fluid, and ex vivo bactericidal activity against arthritis-causing pathogens","volume":"48","author":"Dan","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2019.02.005_bib0090","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1128\/AAC.04579-14","article-title":"Staphylococcal persistence due to biofilm formation in synovial fluid containing prophylactic cefazolin","volume":"59","author":"Dastgheyb","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1185\/03007997209111153","article-title":"Penetration of lincomycin (\u2018Lincocin\u2019) and clindamycin (\u2018Dalacin\u2019C) into the synovial cavity in rheumatoid arthritis","volume":"1","author":"Deodhar","year":"1972","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ijid.2019.02.005_bib0100","first-page":"7","article-title":"The detection of doxycycline activity in human bone","volume":"4","author":"Dornbusch","year":"1976","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1016\/j.ijid.2019.02.005_bib0105","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1128\/AAC.23.5.731","article-title":"Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings","volume":"23","author":"Eron","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0110","first-page":"181","article-title":"Ciprofloxacin concentrations in human fluids and tissues following a single oral dose","volume":"7","author":"Esposito","year":"1987","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1016\/j.ijid.2019.02.005_bib0115","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3109\/17453679308993684","article-title":"Plasma and bone concentrations of cefuroxime and flucloxacillin: oral versus parenteral administration in 20 arthroplasties","volume":"64","author":"Ferrero","year":"1993","journal-title":"Acta Orthop Scand"},{"key":"10.1016\/j.ijid.2019.02.005_bib0120","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1128\/AAC.14.5.723","article-title":"Penetration of methicillin, oxacillin, and cephalothin into bone and synovial tissues","volume":"14","author":"Fitzgerald","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/jac\/23.3.465","article-title":"Aztreonam penetration of bone and soft tissue, after iv infusion and bolus injection","volume":"23","author":"Fracasso","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0130","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-0029-1214161","article-title":"Systemic antimicrobial therapy in osteomyelitis","volume":"23","author":"Fraimow","year":"2009","journal-title":"Semin Plast Surg"},{"key":"10.1016\/j.ijid.2019.02.005_bib0135","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1016\/j.ijid.2011.03.003","article-title":"Ceftriaxone bone penetration in patients with septic non-union of the tibia","volume":"15","author":"Garazzino","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2019.02.005_bib0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0002-9343(85)90264-5","article-title":"Treatment of skin, skin structure, bone, and joint infections with ceftazidime","volume":"79","author":"Gentry","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.ijid.2019.02.005_bib0145","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/AAC.32.9.1320","article-title":"Vancomycin concentrations in infected and noninfected human bone","volume":"32","author":"Graziani","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000238414","article-title":"Penetration of amoxycillin and clavulanic acid into bone","volume":"32","author":"Grimer","year":"1986","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijid.2019.02.005_bib0155","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/ard.31.6.538","article-title":"Penetration of ampicillin and cloxacillin into synovial fluid and the significance of protein binding on drug distribution","volume":"31","author":"Howell","year":"1972","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijid.2019.02.005_bib0160","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/AAC.38.4.905","article-title":"Penetration of piperacillin-tazobactam into cancellous and cortical bone tissues","volume":"38","author":"Incavo","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0165","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3109\/03009747709095460","article-title":"Cephalexin levels in serum, synovial fluid and joint tissues after oral administration","volume":"6","author":"Jalava","year":"1977","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ijid.2019.02.005_bib0170","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.diagmicrobio.2017.03.003","article-title":"Activity of telavancin against Gram-positive pathogens isolated from bone and joint infections in North American, Latin American, European and Asia-Pacific nations","volume":"88","author":"Jones","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2019.02.005_bib0175","first-page":"40","article-title":"Concentrations of cloxacillin, dicloxacillin and flucloxacillin in dental alveolar serum and mandibular bone","volume":"11","author":"K\u00f6ndell","year":"1982","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijid.2019.02.005_bib0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3947\/ic.2014.46.2.125","article-title":"Clinical guidelines for the antimicrobial treatment of bone and joint infections in Korea","volume":"46","author":"Korean Society for Chemotherapy","year":"2014","journal-title":"Infect Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0185","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1128\/AAC.47.12.3964-3966.2003","article-title":"Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci","volume":"47","author":"Kutscha-Lissberg","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003088-200948020-00002","article-title":"Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations","volume":"48","author":"Landersdorfer","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijid.2019.02.005_bib0195","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1128\/AAC.01056-08","article-title":"Penetration of moxifloxacin into bone evaluated by Monte Carlo simulation","volume":"53","author":"Landersdorfer","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0200","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1469-0691.2006.01523.x","article-title":"Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime-fluoroquinolone combination","volume":"12","author":"Legout","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2019.02.005_bib0205","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1128\/AAC.00981-15","article-title":"Oritavancin pharmacokinetics and bone penetration in rabbits","volume":"59","author":"Lehoux","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0210","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/jac\/16.5.637","article-title":"Pharmacokinetic study of ceftazidime in bone and serum of patients undergoing hip and knee arthroplasty","volume":"16","author":"Leigh","year":"1985","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0215","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/jac\/dkf179","article-title":"Brain tissue penetration of ciprofloxacin following a single intravenous dose","volume":"50","author":"Leone","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0220","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2019.02.005_bib0225","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/AAC.04246-14","article-title":"Daptomycin plus fosfomycin, a synergistic combination in experimental implant-associated osteomyelitis due to methicillin-resistant Staphylococcus aureus in rats","volume":"59","author":"Lingscheid","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0230","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jac\/47.4.483","article-title":"The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone","volume":"47","author":"Lovering","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0235","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/dkf066","article-title":"Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement","volume":"50","author":"Lovering","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0240","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.eimc.2015.10.012","article-title":"Evaluation of the tissue diffusion capacity of antibiotics in lower limb ischaemia","volume":"34","author":"Lozano-Alonso","year":"2016","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijid.2019.02.005_bib0245","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/AAC.29.4.710","article-title":"Aztreonam penetration into synovial fluid and bone","volume":"29","author":"MacLeod","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0250","first-page":"520","article-title":"Penetration of vancomycin in cardiac and mediastinal tissues in humans","volume":"42","author":"Martin","year":"1994","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.ijid.2019.02.005_bib0255","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1128\/AAC.36.11.2539","article-title":"Penetration of vancomycin in uninfected sternal bone","volume":"36","author":"Massias","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0260","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/AAC.34.3.398","article-title":"Penetration of ciprofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans","volume":"34","author":"Mertes","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0265","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ijantimicag.2006.08.019","article-title":"Penetration of moxifloxacin into sternal bone of patients undergoing routine cardiopulmonary bypass surgery","volume":"28","author":"Metallidis","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2019.02.005_bib0270","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1128\/AAC.02344-14","article-title":"Penetration of daptomycin into bone and synovial fluid in joint replacement","volume":"58","author":"Montange","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0275","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1010-5182(99)80046-8","article-title":"Perioperative antibiotic prophylaxis in maxillofacial surgery: penetration of clindamycin into various tissues","volume":"27","author":"Mueller","year":"1999","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.ijid.2019.02.005_bib0280","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1469-0691.2009.02761.x","article-title":"Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections","volume":"15","author":"Nguyen","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2019.02.005_bib0285","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/AAC.8.2.220","article-title":"Concentration of clindamycin in human bone","volume":"8","author":"Nicholas","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0290","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2019.02.005_bib0295","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2125.1978.tb00838.x","article-title":"Plasma, bone, hip capsule and drain fluid concentrations of ampicillin and flucloxacillin during total hip replacement after intravenous bolus injection of magnapen","volume":"6","author":"Parsons","year":"1978","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijid.2019.02.005_bib0300","first-page":"503","article-title":"Diffusion of imipenem in synovial fluid","volume":"39","author":"Pechinot","year":"1991","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.ijid.2019.02.005_bib0305","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ijantimicag.2017.12.011","article-title":"Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016)","volume":"51","author":"Pfaller","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2019.02.005_bib0310","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1128\/AAC.00881-10","article-title":"Efficacy of fosfomycin in experimental osteomyelitis due to methicillin-resistant Staphylococcus aureus","volume":"55","author":"Poeppl","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0315","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1128\/AAC.02720-13","article-title":"Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats","volume":"58","author":"Poeppl","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0320","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/jac\/dkf207","article-title":"Linezolid penetration into osteo-articular tissues","volume":"50","author":"Rana","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0325","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jac\/42.4.543","article-title":"Penetration of ceftazidime into bone from severely ischaemic limbs","volume":"42","author":"Raymakers","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0330","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jac\/dkh110","article-title":"Diffusion of levofloxacin into bone and synovial tissues","volume":"53","author":"Rimmele","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0335","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000238294","article-title":"Penetration of parenterally administered rifampicin into bone tissue","volume":"30","author":"Roth","year":"1984","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijid.2019.02.005_bib0340","first-page":"159","article-title":"Investigation of meropenem levels in the human bone marrow blood, bone, joint fluid and joint tissues","volume":"46","author":"Sano","year":"1993","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.ijid.2019.02.005_bib0345","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/pgmj.58.675.20","article-title":"The penetration of metronidazole into synovial fluid","volume":"58","author":"Sattar","year":"1982","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ijid.2019.02.005_bib0350","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.42.1.67","article-title":"Concentrations of some antibiotics in synovial fluid after oral administration, with special reference to antistaphylococcal activity","volume":"42","author":"Sattar","year":"1983","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijid.2019.02.005_bib0355","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/12.3.229","article-title":"The penetration of trimethoprim and sulphamethoxazole into synovial fluid","volume":"12","author":"Sattar","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0360","first-page":"385","article-title":"Bone diffusion of trimethoprim and sulfamethoxazole high pressure liquid chromatography (HPLC) (author\u2019s transl)","volume":"30","author":"Saux","year":"1982","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.ijid.2019.02.005_bib0365","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00003086-197509000-00019","article-title":"Antibiotic bone penetration. Concentrations of methicillin and clindamycin phosphate in human bone taken during total hip replacement","author":"Schurman","year":"1975","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ijid.2019.02.005_bib0370","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2106\/00004623-197860030-00016","article-title":"Cefazolin concentrations in bone and synovial fluid","volume":"60","author":"Schurman","year":"1978","journal-title":"J Bone Joint Surg Am."},{"key":"10.1016\/j.ijid.2019.02.005_bib0375","first-page":"4","article-title":"Antibiotic penetration of synovial fluid in infected and normal knee joints","volume":"30","author":"Schurman","year":"1978","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ijid.2019.02.005_bib0380","first-page":"229","article-title":"Rifampicin diffusion in non-infected human bone (author\u2019s transl)","volume":"128","author":"Sirot","year":"1977","journal-title":"Ann Microbiol (Paris)"},{"key":"10.1016\/j.ijid.2019.02.005_bib0385","first-page":"438","article-title":"Diffusion of rifampicin into spongy and compact bone tissue during total hip prosthesis operation","volume":"31","author":"Sirot","year":"1983","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.ijid.2019.02.005_bib0390","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1128\/AAC.9.1.169","article-title":"Bone concentrations of antimicrobial agents after parenteral administration","volume":"9","author":"Smilack","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0395","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1128\/AAC.00020-07","article-title":"Distribution of radioactivity in bone and related structures following administration of [14C]dalbavancin to New Zealand white rabbits","volume":"51","author":"Solon","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0400","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1128\/AAC.42.12.3086","article-title":"Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole)","volume":"42","author":"Stein","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0405","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1128\/AAC.21.4.601","article-title":"Comparative penetration of metronidazole, clindamycin, chloramphenicol, cefoxitin, ticarcillin, and moxalactam into bone","volume":"21","author":"Summersgill","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0410","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1302\/0301-620X.84B7.12862","article-title":"Antibiotic prophylaxis in surgery of the intervertebral disc: A comparison between gentamicin and cefuroxime","volume":"84","author":"Tai","year":"2002","journal-title":"J Bone Joint SurgBr"},{"key":"10.1016\/j.ijid.2019.02.005_bib0415","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1302\/0301-620X.99B3.BJJ-2016-0328.R1","article-title":"Bone penetration of intravenous flucloxacillin and gentamicin as antibiotic prophylaxis during total hip and knee arthroplasty","volume":"99","author":"Torkington","year":"2017","journal-title":"Bone Joint J"},{"key":"10.1016\/j.ijid.2019.02.005_bib0420","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1302\/0301-620X.99B3.BJJ-2016-0328.R1","article-title":"Bone penetration of intravenous flucloxacillin and gentamicin as antibiotic prophylaxis during total hip and knee arthroplasty","volume":"99-b","author":"Torkington","year":"2017","journal-title":"Bone Joint J"},{"key":"10.1016\/j.ijid.2019.02.005_bib0425","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/jac\/dkq109","article-title":"Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections","volume":"65","author":"Traunmuller","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0430","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0924-8579(01)00423-X","article-title":"Tissue and serum concentrations of levofloxacin in orthopaedic patients","volume":"18","author":"von Baum","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2019.02.005_bib0435","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/24.suppl_B.93","article-title":"Penetration of amoxycillin\/clavulanate into human bone","volume":"24 Suppl B","author":"Weismeier","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0440","first-page":"ii11","article-title":"In vitro activity of ertapenem: review of recent studies","volume":"53 Suppl 2","author":"Wexler","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.02.005_bib0445","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1007\/s11999-011-2111-8","article-title":"Are bone and serum cefazolin concentrations adequate for antimicrobial prophylaxis?","volume":"469","author":"Yamada","year":"2011","journal-title":"Clin Orthop Relat Res"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219300694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219300694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T06:18:42Z","timestamp":1561097922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971219300694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":89,"alternative-id":["S1201971219300694"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2019.02.005","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic penetration into bone and joints: An updated review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2019.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}